Holen Sie sich die Stockscreener-App
26.13
1.59%
0.41
Handel nachbörslich:
26.13
Smith Nephew Plc Adr Aktie (SNN) Neueste Nachrichten
SNN (Smith & Nephew plc ADR) may reap gains as insiders became active recently - Knox Daily
Wound Closure Market Size to Hit USD 26.63 Billion by 2032, Growing at a CAGR of 6.47% - GlobeNewswire Inc.
Goldman Downgrades Riskified Ltd (RSKD) to a Sell from a Neutral - Knox Daily
Smith+Nephew and UFC to host first-of-its-kind medical education course for treatment of injuries in combat sport athletes - GlobeNewswire Inc.
Smith+Nephew appoints new Non-Executive Director - Investing.com
Endoprosthesis Market Size to Surpass USD 60.39 Billion by 2032 at a CAGR of 9.86% - GlobeNewswire Inc.
Weekly Upgrades and Downgrades - InvestorPlace
Smith & Nephew Earnings: Quarterly Sales Suggest China Weakness Into 2025 - Morningstar
Smith & Nephew Sees Challenges in China Market - Morningstar
Smith & Nephew lowers 2024 outlook on China headwinds - Investing.com
Smith+Nephew, JointVue partner on ultrasound-based surgical planning for surgical robotics - Mass Device
Analytical Overview: Smith & Nephew plc ADR (SNN)’s Ratios Tell a Financial Story - The Dwinnex
Smith+Nephew launches new Legion knee system - Mass Device
South Korea Surgical Navigation Systems Market Size & Outlook, 2030 - Grand View Research
The Best Healthcare Stocks to Buy - Morningstar
Smith & Nephew Aligns Director Fees with Shares - TipRanks
China Surgical Navigation Systems Market Size & Outlook, 2030 - Grand View Research
Japan Surgical Navigation Systems Market Size & Outlook, 2030 - Grand View Research
Smith+Nephew announces first Catalystem hip system procedures - Mass Device
Ratios in Focus: Analyzing Smith & Nephew plc ADR (SNN)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex
Smith+Nephew launches Total Ankle patient-matched guides - Mass Device
Upward Trajectory: Smith & Nephew plc ADR (SNN) Posts a Slidee, Closing at 30.67 - The Dwinnex
Saudi Arabia Antimicrobial Wound Care Dressings Market Size & Outlook, 2030 - Grand View Research
Medical Robotics Surgery Market to Grow at CAGR of 10.82% through 2033 - GlobeNewswire Inc.
InfuSystem, Smith+Nephew ink wound therapy distro deal - Mass Device
Smith+Nephew shares jump on strong H1 results and reaffirmed guidance - Investing.com UK
Smith+Nephew wins FDA nod for hip system compatible with Cori surgical robot - Mass Device
Europe First Aid Market Size & Outlook, 2023-2030 - Grand View Research
Smith & Nephew stock gains on Cevian stake (NYSE:SNN) - Seeking Alpha
Smith+Nephew launches pre-op planning tech for surgical robotics - Mass Device
Healthcare Sector - Morningstar
Here’s Why You Should Invest in Smith & Nephew plc (SNN) - Yahoo Finance
Smith+Nephew rolls out new chronic wound treatment tech - Mass Device
7 Robotic Surgery Stocks to Buy for the Future of Healthcare - Yahoo Finance
Smith+Nephew sales are up 7% as 12-point plan progresses - Mass Device
Smith+Nephew kicks off Aetos shoulder system launch at AAOS - Mass Device
Smith+Nephew unveils expanded sports medicine portfolio - Mass Device
Study backs Smith+Nephew Regeneten bioinductive rotator cuff implant - Mass Device
Smith+Nephew launches hip arthroplasty system in India - Mass Device
SNN: Add This Top Equipment Stock to Your Portfolio for a Strong Week Ahead - StockNews.com
Smith+Nephew unveils handheld digital tensioning device for robotic knee surgery - Mass Device
Zimmer Biomet Holdings Inc. stock falls Thursday, underperforms market - MarketWatch
Zimmer Biomet Holdings Inc. stock outperforms market despite losses on the day - MarketWatch
Zimmer Biomet Holdings Inc. stock falls Friday, underperforms market - MarketWatch
8 Newly Undervalued 5-Star Stocks - Morningstar
Zimmer Biomet Holdings Inc. stock rises Friday, still underperforms market - MarketWatch
Zimmer Biomet Holdings Inc. stock outperforms market on strong trading day - MarketWatch
Zimmer Biomet Holdings Inc. stock falls Tuesday, underperforms market - MarketWatch
Zimmer Biomet Holdings Inc. stock underperforms Monday when compared to competitors - MarketWatch
1.16%
0.10%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):